15
Dec

Partners Roche and Exelixis are making their case to regulators with a melanoma-treating combination therapy, filing an FDA application for the fast-tracked treatment as they await European clearance.

…read more

Source: Roche and Exelixis head to the FDA with their melanoma combo

    

0 No comments